As part of its healthymagination mission, GE Healthcare continues to work to improve cost, quality and access in healthcare globally by addressing four critical needs: low cost technology; healthcare IT; innovation accessible to all; and consumer driven healthcare.
At this year’s RSNA, GE will be demonstrating its latest technologies and advancements towards these important goals, across its product lines. Highlights include:
GE Healthcare’s CT and Advantage Workstation team will be showcasing innovative new products and technologies that may enable physicians to diagnose more confidently while improving image clarity, reducing patient dose and enhancing workflow.
Also to be showcased:
GE Healthcare’s CentricityR integrated IT solutions help our customers solve their biggest workflow challenges. From helping our customers to run their business more efficiently and improving the customer service they can deliver, to bringing together previously disconnected clinical data through improved IT integration, GE Healthcare’s innovative, integrated IT solutions are helping to solve the world’s toughest healthcare challenges for our customers.
Our CentricityR solutions portfolio consists of integrated end to end workflow solutions that fall into three categories: Departmental, Enterprise and Community. Our core Radiology focus continues to be on solving workflow challenges specific to Radiology Departments, whether inpatient or outpatient. We also recognize many workflow challenges involve tying together clinical data that may reside in more than one isolated clinical department. This is where our hospital enterprise solutions, such as Vendor Neutral Archive play a critical role breaking down these silos of data. Lastly, some customer challenges involve multiple healthcare providers distributed across a large geographic area and broader healthcare communities. These Community challenges are address by our Image Exchange and OneView solutions.
At RSNA, GE Healthcare will feature significant enhancements to our core Departmental workflow solutions, particularly the integration of AW Server into Centricity PACS, as well as the following: CentricityR Vendor Neutral Archive for the centralized management of images from many departments in an hospital enterprise that can simplify access to, and management of, clinical data, and mobile image and report access through CentricityR Radiology Mobile Access that can now be used to support remote primary diagnosis. We will also be highlighting enhancements to our Image Exchange solution that can tie together disparate PACS across multiple healthcare providers to simplify results sharing and primary reading workload sharing.
In Nuclear Medicine, GE will showcase innovative and advanced technology, specifically the DiscoveryR NM/CT 670, designed to improve workflow, dose management, and overall image quality.
The Discovery NM/CT 670 system combines a newly designed SPECT gantry and GE Healthcare’s latest advancements in nuclear medicine detectors with GE Healthcare’s BrightSpeed Elite 16 slice CT, resulting in shorten acquisition times and enabling more convenient patient scheduling in comparison to separate, conventional SPECT and CT exams. With the Discovery NM/CT 670, the imaging time can be reduced to from an average of 35 minutes to as little as 16 minutes. After a successful global launch, the system has been selected by 100 sites around the world. The new GE Healthcare Discovery NM630 is engineered to help accommodate more patients than previous generation GE nuclear medicine systems.
With its wide bore and table capable of handling patients up to 500lbs, Brivo NM615 will make its global debut at RSNA. Brivo NM615, an advanced Nuclear Medicine gamma camera, is made possible through GE’s innovative EvolutionR technology. This single head system has the ability to achieve shortened scan times, rivaling a dual head system. Brivo NM 615 SPECT capability that gives doctors the ability to lower injected patient dose by as much as 50 percent of those of standard nuclear medicine scanning protocols, or the potential for parents to spend significantly less time on the table during exams, without compromising image quality.
Also to be showcased:
As compared to nuclear medicine gamma cameras using conventional detectors.
GE develops and provides a broad range of products and services to enable healthcare providers to diagnose and treat cancer. We focus on researching new technologies and providing a comprehensive portfolio of solutions to detect disease, diagnose it accurately and treat it effectively. It is about connecting our customers with the right tools for confident decisions and a compassionate patient experience.
We have long recognized the importance of early detection of breast disease. GE pioneered digital mammography more than 10 years ago, and provides one of the most complete digital mammography systems available today. As a result of our investments over the years, GE has one of the largest installed base of mammography equipment in the world.
As we look to increase quality of care and access to care, while reducing its costs, we see screening mammography as a key way to drive the early diagnosis of breast cancer commensurately increasing survival. More diagnostic tools on the same mammography platform, or paired with other imaging and cell biology technologies, can enable clinicians to make better, faster, smarter decisions about their patients. To help reduce cost and increase access, GE Healthcare believes in product ease of use, upgradeability and workflow simplicity. A simple upgrade strategy for our customers helps speed technology to market and increase patient access, while reducing costs.
Today, not all breast cancer is seen with mammography, and we are working on further research and new technologies to detect breast cancer at the earliest stage. Based on scientific studies, the use of supplemental screening with ultrasound or magnetic resonance imaging may be appropriate in addition to mammography for women at increased risk of breast cancer.
GE Healthcare looks to the future of Molecular Imaging through improving cost, quality and access by helping clinicians deliver responsible care, both clinically and economically. This includes a focus on PET treatment assessment, reinforced by a portfolio of quantitative imaging tools to help clinicians detect, diagnose and monitor disease earlier, and to evaluate cancer treatment efficacy more quickly. GE Healthcare has created Q.Suite, a collection of next generation capabilities designed to further quantitative PET by generating more, consistent SUV readings and enabling clinicians to assess treatment response more accurately than ever before.
GE Healthcare is committed to expanding the reach of ultrasound technology. Thus at RSNA, the company will showcase a number of its innovative technologies available globally, including the latest breakthroughs on its LOGIQ, Voluson and ViewPoint platforms. Among the LOGIQ products that GE will feature is the LOGIQR E9, recognized earlier this year by 2011 Top 20 Best in KLAS Awards: Medical Equipment & Infrastructure report as the top general imaging ultrasound system in the market. For ease of use and portability, GE will also be showcasing two of its miniaturized ultrasound devices the Venue 40, a miniaturized ultrasound platform created for smaller clinical spaces; and Vscan, a pocket sized visualization tool developed to provide physicians with imaging capabilities at the point of care.
With new technology investments in radiography, fluoroscopy, mammography and bone densitometry, GE X Ray is committed to helping physicians make each patient’s experience a comforting one. GE XRay’s dedication to innovation continues this year with the introduction of products like the CoreScanR body composition application designed to quantify visceral belly fat, a suite of advanced mobile radiology units called OptimaR XR220amx, Optima XR200amx and BrivoR XR285amx, and even more uses for GE’s revolutionary FlashPadR digital wireless detector.
R notes registered trademark of General Electric Company